Characteristics of study population
| Values are mean (SD, range) or absolute numbers. | |
| CT data are given for observer 1. | |
| COPD, chronic obstructive pulmonary disease; AAT, α1-antitrypsin deficiency; IPF, idiopathic pulmonary fibrosis; LAM, lymphangioleiomyomatosis; PPH, pulmonary arterial hypertension; CT, computed tomography; AT, air trapping; BO, bronchiolitis obliterans; FEV1, forced expiratory volume in 1 second. | |
| Type of transplantation | |
| Single lung (n) | 21 |
| Double lung (n) | 16 |
| Heart lung (n) | 1 |
| Diagnosis | |
| Cystic fibrosis (n) | 13 |
| Emphysema/COPD (n) | 11 |
| AAT, IPF and LAM (n) | 3 each |
| PAH, idiopathic obliterative bronchiolitis (n) | 2 each |
| Langerhans cell histiocytosis, sarcoidosis (n) | 1 each |
| Spirometry | |
| FEV1 at baseline CT (% baseline post-transplant) | 82 (18, 34–100) |
| FEV1 at follow up CT (% baseline post-transplant) | 77 (21, 27–100) |
| CT scores | |
| CTAT score at baseline CT (unit) | 47 (23, 0–100) |
| CTAT score at follow up CT (unit) | 51 (23, 0–100) |
| CTBO score at baseline CT (unit) | 7 (4, 1–16) |
| CTBO score at follow up CT (unit) | 7 (5, 0–24) |